Usefulness of serum carbohydrate antigen 19-9 in surgical management of mass-forming intrahepatic cholangiocarcinoma

Japanese Journal of Gastroenterological Surgery

Volumn 35, Issue 2, 2002, Pages 130-134

  Matsumura, Naoki ^a   Yamamoto, Masakazu ^a   Takasaki, Ken ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Carbohydrate antigen 19 9; Mass forming intrahepatic cholangiocarcinoma; Sialyl Lewis A (Lea), prognostic factor

Indexed keywords

CARBOHYDRATE ANTIGEN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD LEVEL; CANCER INVASION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; TREATMENT OUTCOME;

EID: 0036192293     PISSN: 03869768     EISSN: None     Source Type: Journal    
DOI: 10.5833/jjgs.35.130     Document Type: Article

References (17)

1. Lymph node metastasis in intrahepatic cholangiocarcinoma
2. Long-term survival and prognostic factor in the surgical treatment of mass-forming type cholangiocarcinoma
3. Hepatocellular carcinoma, metastatic abdominal lymph nodes identified by comruted tomography
4. Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer
5. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma